Beauty Industry Mergers as a Tool for Strategic Focus
Beauty industry mergers are strategic transactions in which companies buy, sell, or combine cosmetics and skincare brands to sharpen portfolios, improve financial strength, and respond to changing consumer demand across makeup, fragrance, and skin health. Recent luxury beauty M&A activity reveals a clear pattern: the biggest players are no longer chasing scale at any cost, but are instead using a sharper cosmetics acquisition strategy to rebalance where and how they grow. From makeup brand consolidation to targeted divestitures, deals are being judged on whether they unlock profitable expansion, not just headline size. The latest moves from Waldencast, Proya, Estée Lauder, and Puig show each group redefining what belongs in its core portfolio. Together, these decisions hint at a new phase where focus, category expertise, and disciplined pricing matter more than empire building.
Waldencast Sells Obagi to Double Down on Milk Makeup
Waldencast’s sale of Obagi Medical to private equity firm Bridgepoint for USD 460 million (approx. RM2,116 million) is a textbook example of pruning to grow. The transaction leaves Waldencast centered on Milk Makeup, combining color cosmetics and skincare under a single, consumer-facing brand. Waldencast, originally formed as a SPAC that acquired both Obagi Medical and Milk Makeup, had already sold Obagi Japan trademark rights for USD 82.5 million (approx. RM380 million) and refinanced debt to reduce leverage. Now, the company plans to repay its outstanding senior term loan and reinvest in Milk. According to Waldencast’s board, “The sale meaningfully strengthens the company’s balance sheet and enables a sharper strategic focus on Milk Makeup, a brand with significant global growth potential.” In a market where makeup brand consolidation can unlock scale in marketing, distribution, and innovation, this move turns a multi-brand platform into a single-brand growth story.
Proya Takes Control of Flower Knows to Build Color Power
While Waldencast is narrowing its scope, Proya is broadening its reach through targeted makeup acquisition. Proya acquired an additional 12.6% stake in Flower Knows for CNY 351 million, lifting its indirect ownership to 51% and bringing the whimsical makeup label fully into its consolidated results. Flower Knows has quickly become a profit engine, generating CNY 1.7 billion in revenue and CNY 280 million in net profit last year, making it Proya’s second-largest cosmetics brand. The deal aligns with Proya’s multi-brand, multi-category strategy and reflects a pivot toward color cosmetics as growth in its core skincare business slows. By pairing Flower Knows with existing makeup names such as Timage and Insbaha, Proya is building a more complete color portfolio and gaining scale in marketing and product development. This is makeup brand consolidation with a clear purpose: capturing rising demand in color while diversifying earnings.
Estée Lauder, Puig and the Price of Luxury Beauty M&A
At the top end of luxury beauty M&A, price discipline and control are proving as important as strategic fit. Estée Lauder confirmed that merger talks with Puig collapsed over valuation, with its President and CEO Stephane de La Faverie stating that if growth and profitability cannot be reached “at the right price point, then that is not an option.” Puig, for its part, has made clear it is not for sale and will pursue a selective, value-focused mergers and acquisitions agenda. Before talks with Estée Lauder, Puig explored a long-term beauty licensing tie-up with Kering that would have included a minority stake, but those negotiations also ended without a deal. Kering then turned to a partnership with L’Oréal instead. Image-conscious brands want the reach of scaled platforms, yet family-controlled groups such as Puig are signaling that governance and economics must align before any cosmetics acquisition strategy advances.
From Empire Building to Portfolio Discipline
Across these moves, a common theme emerges: leading players are trading empire building for portfolio discipline. Waldencast is exiting medical aesthetics to concentrate capital and management attention on Milk Makeup, while Proya is investing into Flower Knows to deepen its presence in color cosmetics. Estée Lauder is keeping the door open to acquisitions that fit its financial criteria and is said to be reviewing options for brands like Too Faced, Smashbox, and Dr. Jart+, suggesting selective divestitures may follow. Puig, meanwhile, positions itself as an independent platform that will only pursue deals that complement its existing fragrance and cosmetics strengths. For investors and brands, this phase of beauty industry mergers is less about blockbuster combinations and more about fine-tuning. The winners are likely to be companies that use luxury beauty M&A to clarify, not complicate, their strategic focus.
